期刊文献+

SDF-1/CXCR4对喉癌细胞归巢的作用 被引量:3

Effect of SDF-1/CXCR4 axis to homing of laryngeal carcinoma cell Hep-2
原文传递
导出
摘要 目的在体外探讨血管内皮生长因子C(vascular endothelial growth factor C,VEGF-C)、趋化因子受体(Cys-X-Cys receptor4,CXCR4)及其配体基质细胞衍生因子-1(stromal cell-derived factor1,SDF-1)在喉癌Hep-2细胞株中的表达及其在喉癌细胞归巢中的作用。方法①分别用RT-PCR及Western blot检测喉癌Hep-2细胞株中CXCR4 mRNA和蛋白的表达和重组人SDF-1与CXCR4特异性拮抗剂(AMD3100)作用前后喉癌Hep-2细胞株中VEGF-CmRNA和蛋白表达水平的变化;②用甲基噻唑基四唑(MTT比色法)测定不同浓度重组人SDF-1以及AMD3100作用前后Hep-2细胞增殖率的变化;③Transwell小室迁移及体外侵袭实验检测不同浓度重组人SDF-1以及AMD3100对Hep-2细胞趋化活性的影响。结果①在mRNA以及蛋白水平,CXCR4及VEGF-C在Hep-2细胞株中均有高表达,在不同浓度重组人SDF-1(1、10、100ng/ml)作用Hep-2细胞株24h后,VEGF-C的表达明显上调,且有明显的剂量依赖性,并能被1μg/ml的CXCR4的特异性拮抗剂AMD3100阻断;②与对照组(未处理的Hep-2细胞)和10ng/mlSDF-1组比较,100ng/mlSDF-1组有明显促进喉癌细胞增殖的作用(P<0.05),并能被1μg/ml的AMD3100阻断;③与对照组和10ng/mlSDF-1组比较,100ng/mlSDF-1组同样有明显的促喉癌细胞迁移和侵袭的作用(P<0.05),同样也能被1μg/ml的AMD3100所阻断。结论 SDF-1/CXCR4生物轴与VEGF-C协同促进喉癌细胞归巢,可作为干预喉癌淋巴转移的新手段。 Objective To investigate the in vitro expressions of chamotatic factor CXCL12 [also known as stromal cell-derived factor 1 (SDF-1)],the receptor of the factor,Cys-X-Cys receptor 4 (CXCR4) and vascular endothelial growth factor C (VEGF-C) in human laryngeal carcinoma cell line Hep-2 and their roles in the homing of laryngeal carcinoma. Methods The expressions of CXCR4 mRNA and protein in Hep-2 cells was detected by RT-PCR and Western blotting,the expression of VEGF-C also was evaluated before and after incubated with SDF-1 (1,10,100 ng/ml) or the antagonist of CXCR4 AMD3100. Methythiazolyltetrazolium (MTT) assay was used to analyze the effect of different concentrations of SDF-1 on the proliferation of Hep-2 cells. Transwell invasion chamber and matrigel were used to evaluate the effect of various concentrations of SDF-1 and AMD3100 on the migration and invasion of Hep-2 cells. Results 1)The CXCR4 and VEGF-C were both overexpressed at mRNA and protein level in Hep-2 cells,and the expression of VEGF-C in Hep-2 cells was up-regulated with a concentration-dependent model,which was inhibited by CXCR4 antagonist (P0.05). 2)SDF-1(100 ng/ml) significantly enhanced the proliferation of Hep-2 cells compared with the control and 10 ng/ml SDF-1 groups (24 h:0.585±0.051 vs 0.425±0.045 and 0.428±0.039,P0.05; 48 h:0.631±0.062 vs 0.497±0.067 and 0.532±0.039,P0.01). This enhancing effect of SDF-1 was significantly inhibited by 1 μg/ml AMD3100. 3)The levels of migration and invasion of the Hep-2 cells treated with 100 ng/ml SDF-1 were significantly higher than those in the control and 10 ng/ml SDF-1 (migration:286.7±24.7 vs 48.0±7.2 and 147.7±37.0; invasion:40.5±4.5 vs 4.0±1.0 and 17.7±2.0,P0.05),and was strongly inhibited by 1 μg/ml AMD3100. Conclusion SDF-1/CXCR4 can in coordination with VEGF-C promote homing of laryngeal carcinoma cell line Hep-2,and may be a new pathway to prevent laryngeal carcinoma lymph node metastasis.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2010年第12期1316-1320,共5页 Journal of Third Military Medical University
基金 重庆市卫生局科研基金(2007-2-070) 重庆市卫生局重点项目(2008-1-16)~~
关键词 细胞系 肿瘤 喉肿瘤 血管内皮生长因子-C 受体 CXCR4 趋化因子CXCL12 cell line tumor laryngeal neoplasms vascular endothelial growth factor C receptors CXCR4 chemokine CXCL12
  • 相关文献

参考文献6

二级参考文献42

共引文献77

同被引文献29

  • 1刘成军,许峰,匡凤梧,党润,卢仲毅,王兴勇.基质金属蛋白酶及其组织抑制剂在高氧性肺损伤中的变化[J].实用儿科临床杂志,2004,19(10):842-844. 被引量:3
  • 2黄绍崧,杨辉,卞修武,李成仁.趋化因子受体CXCR4的表达与垂体腺瘤侵袭性关系的初步研究[J].第三军医大学学报,2005,27(20):2063-2066. 被引量:7
  • 3Jobe A H, Bancalari E. Bronchopulmonary dysplasia [ J ]. Am J Respair Crit Care Med, 2001, 163(7) : 1723 -1729.
  • 4Song J S, Kang C M, Kang H H, et al. Inhibitory effect of CXC chemo- kine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis [J]. Exp Mol Med, 2010, 42(6) : 465 -472.
  • 5Young K C, Tortes E, Hatzstergos K E, et al. Inhibition of the SDF- 1/CXCR4 axis attenuates neonatal hypoxia-iuduced pulmonary hypertension [J]. Circ Res, 2009, 104(11): 1293-1301.
  • 6Mehrad B, Burdick M D, Strieter R M. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis [ J ]. Int J Biochem Cell Biol, 2009, 41 (8/9) : 1708 - 1718.
  • 7Strieter R M, Keeley E C, Burdick M D, et al. The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis[ J]. Trans Am Clin Climatol Assoc, 2009, 120:49 -59.
  • 8Phillips R J, Burdick M D, Hong K, et al. Circulating fibrocytes traf- fic to the lungs in response to CXCL12 and mediate fibrosis[J]. J Clin Invest, 2004, 114(3) : 438 -446.
  • 9Xu J, Mora A, Shim H, et al. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis [ J ]. Am J Respir Cell Mol Biol, 2007, 37(3) : 291 -299.
  • 10Deng C, Wang J, Zou Y, et al. Characterization of fibroblasts recruited from bone marrow derived precursor in neonatal Bronchopulmonary dysplasia (BPD) mice[J]. J Appl Physiol, 2011. [Epub ahead of print].

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部